Loraine Upham Email

Senior Director, Business Operations and Hypoxic Ischemic Encephalopathy Program Leader . ReAlta Life Sciences

Current Roles

Employees:
20
Revenue:
$3.1M
About
ReAlta Life Sciences, Inc. is a clinical stage biotech company dedicated to harnessing the power of the immune system through its EPICC technology platform, comprised of a family of over 160 engineered peptides, to address life-threatening medical needs. The peptide family leverages one billion years of evolution that has enabled the human astrovirus to inhibit components of the innate immune system. This novel class of therapeutics exploits the virus' dual targeting approach and enables the rebalancing of complement and inflammatory processes in the body. The company's pipeline is led by RLS-0071, which has been granted Orphan Drug Designation by the U.S. Food and Drug Administration and European Medicines Agency for the treatment of hypoxic-ischemic encephalopathy (HIE) in neonates, and is also being developed as a treatment for acute lung injury secondary to COVID-19. The company launched in 2018, and is located in Norfolk, Virginia. For more information, please visit www.realtalifesciences.com.
ReAlta Life Sciences Address
5665 Lowery Rd
Norfolk, VA
United States
ReAlta Life Sciences Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.